menu search

CARM / Carisma Therapeutics to Present at Upcoming Healthcare Industry Conferences in May 2023

Carisma Therapeutics to Present at Upcoming Healthcare Industry Conferences in May 2023
PHILADELPHIA , May 5, 2023 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma"), a clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that the company will present at several healthcare industry conferences in May 2023. These conferences include: American Society of Gene & Cell Therapy (ASGCT) 26th Annual Meeting 2023 Carisma is giving an oral presentation during the meeting: Chris Sloas, Ph.D. Read More
Posted: May 5 2023, 16:30
Author Name: PRNewsWire
Views: 092042

CARM News  

Carisma to Present First Results From in vivo CAR-M Collaboration with Moderna at SITC 2023

By PRNewsWire
October 25, 2023

Carisma to Present First Results From in vivo CAR-M Collaboration with Moderna at SITC 2023

-Late-breaking abstract to be presented on November 3 rd at 11:30 am PT highlighting pre-clinical data with Moderna -Two additional pre-clinical data more_horizontal

3 Top Under-$5 Stocks for Strong Gains and Positive Outlook

By InvestorPlace
October 12, 2023

3 Top Under-$5 Stocks for Strong Gains and Positive Outlook

To clearly set expectations from the get-go, these top stocks under $5 represent extraordinary risks. As either small or even micro-capitalization ent more_horizontal

Carisma Therapeutics to Present at the JMP Securities Life Sciences Conference

By PRNewsWire
May 8, 2023

Carisma Therapeutics to Present at the JMP Securities Life Sciences Conference

PHILADELPHIA , May 8, 2023 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical c more_horizontal

Carisma Therapeutics to Present at Upcoming Healthcare Industry Conferences in May 2023

By PRNewsWire
May 5, 2023

Carisma Therapeutics to Present at Upcoming Healthcare Industry Conferences in May 2023

PHILADELPHIA , May 5, 2023 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma"), a clinical stage biopharmaceutical company focused o more_horizontal


Search within

Pages Search Results: